ESSILORLUXOTTICA (1EL.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1EL • FR0000121667

255.8 EUR
-0.7 (-0.27%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

4

1EL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1EL while its profitability can be described as average. 1EL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • 1EL had positive earnings in the past year.
  • 1EL had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1EL has been profitable.
  • 1EL had a positive operating cash flow in each of the past 5 years.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • The Return On Assets of 1EL (3.84%) is comparable to the rest of the industry.
  • The Return On Equity of 1EL (6.29%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 5.39%, 1EL is in line with its industry, outperforming 47.06% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 1EL is below the industry average of 9.62%.
  • The last Return On Invested Capital (5.39%) for 1EL is above the 3 year average (4.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROIC 5.39%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.74%, 1EL is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
  • 1EL's Profit Margin has improved in the last couple of years.
  • 1EL has a Operating Margin (12.86%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of 1EL has grown nicely.
  • 1EL has a better Gross Margin (61.91%) than 64.71% of its industry peers.
  • In the last couple of years the Gross Margin of 1EL has remained more or less at the same level.
Industry RankSector Rank
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1EL is destroying value.
  • Compared to 1 year ago, 1EL has more shares outstanding
  • The number of shares outstanding for 1EL has been increased compared to 5 years ago.
  • Compared to 1 year ago, 1EL has a worse debt to assets ratio.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.92 indicates that 1EL is not in any danger for bankruptcy at the moment.
  • 1EL has a better Altman-Z score (3.92) than 70.59% of its industry peers.
  • The Debt to FCF ratio of 1EL is 4.18, which is a neutral value as it means it would take 1EL, 4.18 years of fcf income to pay off all of its debts.
  • 1EL's Debt to FCF ratio of 4.18 is fine compared to the rest of the industry. 1EL outperforms 66.18% of its industry peers.
  • A Debt/Equity ratio of 0.25 indicates that 1EL is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.25, 1EL is doing good in the industry, outperforming 69.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Altman-Z 3.92
ROIC/WACC0.69
WACC7.79%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that 1EL may have some problems paying its short term obligations.
  • 1EL has a Current ratio of 0.97. This is amonst the worse of the industry: 1EL underperforms 80.88% of its industry peers.
  • A Quick Ratio of 0.67 indicates that 1EL may have some problems paying its short term obligations.
  • 1EL's Quick ratio of 0.67 is on the low side compared to the rest of the industry. 1EL is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.67
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

5

3. Growth

3.1 Past

  • 1EL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.00%.
  • Measured over the past years, 1EL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.01% on average per year.
  • 1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.45%.
  • Measured over the past years, 1EL shows a quite strong growth in Revenue. The Revenue has been growing by 8.80% on average per year.
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%

3.2 Future

  • Based on estimates for the next years, 1EL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.60% on average per year.
  • The Revenue is expected to grow by 7.56% on average over the next years.
EPS Next Y5.69%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
EPS Next 5Y9.6%
Revenue Next Year5.99%
Revenue Next 2Y6.94%
Revenue Next 3Y7.45%
Revenue Next 5Y7.56%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • 1EL is valuated quite expensively with a Price/Earnings ratio of 37.23.
  • 1EL's Price/Earnings ratio is in line with the industry average.
  • 1EL is valuated rather expensively when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 31.82 indicates a quite expensive valuation of 1EL.
  • 64.71% of the companies in the same industry are cheaper than 1EL, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.51, 1EL is valued a bit more expensive.
Industry RankSector Rank
PE 37.23
Fwd PE 31.82
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 1EL's Enterprise Value to EBITDA is on the same level as the industry average.
  • 1EL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 35.23
EV/EBITDA 19.52
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1EL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.54
PEG (5Y)2.32
EPS Next 2Y8.8%
EPS Next 3Y10.77%

More info and screens

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.55%, 1EL has a reasonable but not impressive dividend return.
  • 1EL's Dividend Yield is a higher than the industry average which is at 1.03.
  • Compared to an average S&P500 Dividend Yield of 1.83, 1EL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

  • The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1EL pays out 22.97% of its income as dividend. This is a sustainable payout ratio.
  • 1EL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.97%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

More info and screens

ESSILORLUXOTTICA

BIT:1EL (2/3/2026, 7:00:00 PM)

255.8

-0.7 (-0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-16
Earnings (Next)02-11
Inst Owners28.97%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap118.47B
Revenue(TTM)27.24B
Net Income(TTM)2.38B
Analysts81.94
Price Target331.34 (29.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP22.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.11%
PT rev (3m)14.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.45%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 37.23
Fwd PE 31.82
P/S 4.35
P/FCF 35.23
P/OCF 24.11
P/B 3.13
P/tB N/A
EV/EBITDA 19.52
EPS(TTM)6.87
EY2.69%
EPS(NY)8.04
Fwd EY3.14%
FCF(TTM)7.26
FCFY2.84%
OCF(TTM)10.61
OCFY4.15%
SpS58.82
BVpS81.67
TBVpS-5.08
PEG (NY)6.54
PEG (5Y)2.32
Graham Number112.36
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROCE 6.93%
ROIC 5.39%
ROICexc 5.71%
ROICexgc 35.85%
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
FCFM 12.34%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
ROICexc(3y)5.06%
ROICexc(5y)3.96%
ROICexgc(3y)34.05%
ROICexgc(5y)28.3%
ROCE(3y)6.22%
ROCE(5y)4.81%
ROICexgc growth 3Y0.01%
ROICexgc growth 5Y9.27%
ROICexc growth 3Y12.06%
ROICexc growth 5Y11.05%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Debt/EBITDA 1.41
Cap/Depr 49.38%
Cap/Sales 5.69%
Interest Coverage 250
Cash Conversion 73.95%
Profit Quality 141.24%
Current Ratio 0.97
Quick Ratio 0.67
Altman-Z 3.92
F-Score7
WACC7.79%
ROIC/WACC0.69
Cap/Depr(3y)51.19%
Cap/Depr(5y)45.17%
Cap/Sales(3y)6.06%
Cap/Sales(5y)5.58%
Profit Quality(3y)145.59%
Profit Quality(5y)677.55%
High Growth Momentum
Growth
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
EPS Next Y5.69%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
EPS Next 5Y9.6%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%
Revenue Next Year5.99%
Revenue Next 2Y6.94%
Revenue Next 3Y7.45%
Revenue Next 5Y7.56%
EBIT growth 1Y6.6%
EBIT growth 3Y15.34%
EBIT growth 5Y15.84%
EBIT Next Year56.89%
EBIT Next 3Y23.64%
EBIT Next 5Y17.35%
FCF growth 1Y3.16%
FCF growth 3Y-1.57%
FCF growth 5Y6.95%
OCF growth 1Y2.06%
OCF growth 3Y2.36%
OCF growth 5Y8.12%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1EL.MI.


Can you provide the valuation status for ESSILORLUXOTTICA?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 6 / 10.


What is the financial health of ESSILORLUXOTTICA (1EL.MI) stock?

The financial health rating of ESSILORLUXOTTICA (1EL.MI) is 3 / 10.


Can you provide the expected EPS growth for 1EL stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 5.69% in the next year.